Role of Galphaq in smooth muscle cell proliferation.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal of Vascular Surgery

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 14981460
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular mechanisms of angiotensin II-induced vascular injury

  2003cited by this paper
• A unique fold of phospholipase C-beta mediates dimerization and interaction with G alpha q.

  2002cited by this paper
• Sphingosine-1-phosphate induces G(alphai)-coupled, PI3K/ras-dependent smooth muscle cell migration.

  2002cited by this paper
• G Protein Pathways

  2002cited by this paper
• Novel mechanisms for feedback regulation of phospholipase C-beta activity.

  2002cited by this paper
• Vascular smooth muscle growth: autocrine growth mechanisms.

  2001cited by this paper
• G-protein expression and intimal hyperplasia after arterial injury: a role for Galpha(i) proteins.

  2001cited by this paper
• Transactivation: a novel signaling pathway from angiotensin II to tyrosine kinase receptors.

  2001cited by this paper
• [Roles of Galphaq/11 mediated- and platelet-derived growth factor mediated-signal transduction pathways in rat aorta restenosis].

  2001cited by this paper
• Regulation of Mitogen-Activated Protein Kinase Signaling Networks by G Protein-Coupled Receptors

  2000cited by this paper
• Modulation of vascular development and injury by angiotensin II.

  1999cited by this paper
• Intracoronary stenting: an overview for the clinician.

  1999cited by this paper
• Phospholipase C-beta1 directly accelerates GTP hydrolysis by Galphaq and acceleration is inhibited by Gbeta gamma subunits.

  1999cited by this paper
• G protein signaling and vein graft intimal hyperplasia: reduction of intimal hyperplasia in vein grafts by a Gbetagamma inhibitor suggests a major role of G protein signaling in lesion development.

  1998cited by this paper
• The regulation of p42/p44 mitogen-activated protein kinases in the injured rat carotid artery.

  1997cited by this paper
• Remodeling with neointima formation in the mouse carotid artery after cessation of blood flow.

  1997cited by this paper
• Angiotensin II activates the beta 1 isoform of phospholipase C in vascular smooth muscle cells.

  1997cited by this paper
• The temporal sequence of G-protein expression in intimal hyperplasia.

  1996cited by this paper
• Characterisation of angiotensin II receptor mediated responses and inhibition of intimal hyperplasia in experimental vein grafts by the specific angiotensin II receptor inhibitor, L158,809.

  1996cited by this paper
• Restenosis: the cost to society.

  1995cited by this paper
• Pathobiology of intimal hyperplasia

  1994cited by this paper
• The expression and function of G-proteins in experimental intimal hyperplasia.

  1994cited by this paper
• Selective activation of phospholipase C by recombinant G-protein alpha- and beta gamma-subunits.

  1994cited by this paper
• Characterization of the angiotensin II AT1 receptor subtype involved in DNA synthesis in cultured vascular smooth muscle cells

  1994cited by this paper
• G proteins in signal transduction: the regulation of phospholipase C.

  1993cited by this paper
• Culture of renal arteriolar smooth muscle cells. Mitogenic responses to angiotensin II.

  1992cited by this paper
• Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo

  1992cited by this paper
• Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall.

  1991cited by this paper

• Going Rogue: Mechanisms, Regulation, and Roles of Mutationally Activated Gα in Human Cancer

  2024cites this paper
• Spatiotemporal Optical Control of Gαq-PLCβ Interactions.

  2023cites this paper
• Spatiotemporal optical control of Gαq-PLCβ interactions

  2023cites this paper
• Gαq Is the Specific Mediator of PAR-1 Transactivation of Kinase Receptors in Vascular Smooth Muscle Cells

  2022cites this paper
• Recent achievements in developing selective Gq inhibitors

  2020cites this paper
• Heterotrimeric G Proteins as Therapeutic Targets in Drug Discovery.

  2019cites this paper
• NFATc1-E2F1-LMCD1-Mediated IL-33 Expression by Thrombin Is Required for Injury-Induced Neointima Formation.

  2019cites this paper
• LIM and cysteine-rich domains 1 is required for thrombin-induced smooth muscle cell proliferation and promotes atherogenesis

  2018cites this paper
• Gaq proteins: molecular pharmacology and therapeutic potential

  2017influential citation
• A frizzled quest to dissect the molecular pharmacology of WNT signaling : from biology to signaling mechanism(s)

  2017cites this paper
• Structure, Function, Pharmacology, and Therapeutic Potential of the G Protein, Gα/q,11

  2015influential citation
• Assessing the role of Gαq/11 in cellular responses: an analysis of investigative tools

  2014cites this paper
• Alternative approaches to the prevention of coronary In-stent restenosis

  2014cites this paper
• Structural Insights into Phospholipase C-β Function

  2013cites this paper
• KISS1R induces invasiveness of estrogen receptor-negative human mammary epithelial and breast cancer cells.

  2013cites this paper
• Gαq G proteins modulate MMP-9 gelatinase during remodeling of the murine femoral artery.

  2013cites this paper
• Microribonucleic acids for prevention of plaque rupture and in-stent restenosis: "a finger in the dam".

  2011cites this paper
• RGS5, RGS4, and RGS2 expression and aortic contractibility are dynamically co-regulated during aortic banding-induced hypertrophy.

  2008cites this paper
• Transcriptional profiling of the megabladder mouse: A unique model of bladder dysmorphogenesis

  2008cites this paper
• Sphingosine-1-phosphate-induced oxygen free radical generation in smooth muscle cell migration requires Galpha12/13 protein-mediated phospholipase C activation.

  2007cites this paper
• Pharmacological properties of YM-254890, a specific Gαq/11 inhibitor, on thrombosis and neointima formation in mice

  2005cites this paper